These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 482271)

  • 1. [Qualitative reaction for determining rifampicin in the urine for the purpose of controlling patient intake of this preparation].
    Tatarinova NV; Zhuk NA; Chukanov VI
    Probl Tuberk; 1979 Aug; (8):62-5. PubMed ID: 482271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa; Manzhikova SR
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].
    Winsel K; Eule H; Werner E; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):253-6. PubMed ID: 4011658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 6. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 7. [The inactivation of glucocorticosteroid hormones by rifampicin when it is used intermittently].
    Basov PV; Prokhorov NN; Spesivtsev OG
    Vrach Delo; 1990 Nov; (11):20-2. PubMed ID: 2098973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin].
    Reĭle EE; Polushkina EE
    Probl Tuberk; 1987; (2):22-5. PubMed ID: 3575271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inactivation of glucocorticoid hormones by rifampicin in the treatment of patients with pulmonary tuberculosis].
    Spesivtsev OG; Basov PV
    Probl Tuberk; 1988; (12):27-8. PubMed ID: 3244680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delayed results of treatment of pulmonary tuberculosis with rifampicin].
    Fréour P; Bernadou M; Chomy P
    Gruzlica; 1974 May; 42(5):439-42. PubMed ID: 4464235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 15. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
    Gomi J; Aoyagi T; Fukuhara Y; Yamaguchi T; Matsumiya T
    Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
    Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Excretion of rifampin with urine during treatment of patients with tuberculosis].
    Ioffe RA
    Probl Tuberk; 1973; 51(12):43-6. PubMed ID: 4782103
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests.
    Burkhardt KR; Nel EE
    S Afr Med J; 1980 Jun; 57(24):981-5. PubMed ID: 7404075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.